GlassScriptPhysician profile
Micah J Galvas
NPI 1992125975
$1,808.21
in general payments reported to CMS, 2019-2025
13 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $98.21 · 2022: $255 · 2023: $558 · 2024: $389 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $520.65 | 2022-2024 | Xarelto |
| Heartflow, INC. | $321.26 | 2025 | |
| Pfizer INC. | $258.07 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.53 | 2021-2025 | Lifevest |
| Glaxosmithkline, LLC. | $114.30 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $103.38 | 2022 | |
| Edwards Lifesciences Corporation | $93.79 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| E.R. Squibb & Sons, L.L.C. | $83.58 | 2022-2023 | Camzyos |
| Ucb, INC. | $66.19 | 2023-2024 | Briviact |
| Boston Scientific Corporation | $39.85 | 2023 | Watchman Flx |
| Scpharmaceuticals INC. | $22.89 | 2025 | |
| Mallinckrodt Hospital Products INC. | $16.87 | 2025 | Terlivaz |
| Novo Nordisk INC | $14.85 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Galvas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.